Profile data is unavailable for this security.
About the company
STAAR Surgical Company designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems used to deliver the lenses into the eye. These lenses provide visual freedom for patients, lessening or eliminating the reliance on glasses or contact lenses. The Company is a manufacturer of lenses used worldwide in corrective or refractive surgery. It sells its products in approximately 75 countries, with direct distribution in Japan, Germany, Spain, the United States, Canada, the United Kingdom, and Singapore, with a combination of direct distribution and independent distribution in China, Korea, India, France, Benelux, and Italy. The Company markets and sells ICLs for refractive surgery to treat myopia (nearsightedness) as its EVO family of lenses. The Company’s EVO family of lenses includes its EVO ICL, EVO+ ICL, and EVO Visian ICL. The Company also markets and sells an ICL lens to treat hyperopia (farsightedness), which is called Visian ICL.
- Revenue in USD (TTM)332.94m
- Net income in USD16.61m
- Incorporated1986
- Employees1.06k
- LocationSTAAR Surgical Co1911 Walker AveMONROVIA 91016United StatesUSA
- Phone+1 (626) 303-7902
- Fax+1 (302) 636-5454
- Websitehttps://www.staar.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BioLife Solutions Inc | 121.17m | -53.87m | 1.08bn | 409.00 | -- | 3.36 | -- | 8.93 | -1.21 | -1.64 | 2.69 | 6.97 | 0.2999 | 1.99 | 5.39 | 296,254.30 | -13.33 | -13.76 | -14.60 | -15.04 | 41.27 | 36.76 | -44.46 | -42.99 | 1.81 | -5.98 | 0.0651 | -- | -11.43 | 48.65 | 52.49 | -- | 86.35 | -- |
| Avanos Medical Inc | 682.40m | 7.00m | 1.11bn | 3.77k | 157.60 | 0.9074 | 21.26 | 1.63 | 0.1532 | 0.1671 | 14.71 | 26.62 | 0.4105 | 1.93 | 5.20 | 180,960.00 | 0.4211 | -0.6527 | 0.4737 | -0.7338 | 55.82 | 54.45 | 1.03 | -1.60 | 1.49 | 7.06 | 0.1253 | -- | -1.58 | 0.6357 | -146.05 | -- | -18.37 | -- |
| Establishment Labs Holdings Inc | 151.35m | -83.20m | 1.22bn | 857.00 | -- | 27.04 | -- | 8.04 | -3.11 | -3.11 | 5.62 | 1.61 | 0.5307 | 0.8525 | 2.72 | 166,685.00 | -29.17 | -33.22 | -34.29 | -41.12 | 66.04 | 64.73 | -54.97 | -43.19 | 2.91 | -20.68 | 0.8114 | -- | 2.13 | 21.96 | -4.38 | -- | 69.16 | -- |
| Owens & Minor, Inc. | 10.53bn | -42.44m | 1.22bn | 13.70k | -- | 1.42 | 5.10 | 0.1162 | -0.5532 | -0.5532 | 137.98 | 11.17 | 1.99 | 6.95 | 15.78 | 768,728.30 | -0.8014 | 1.32 | -1.25 | 2.07 | 20.78 | 16.48 | -0.403 | 0.5614 | 0.5141 | 2.11 | 0.7076 | 0.798 | 3.80 | 1.87 | -284.47 | -- | 25.91 | -- |
| Pulse Biosciences Inc | 0.00 | -44.02m | 1.25bn | 56.00 | -- | 41.63 | -- | -- | -0.7916 | -0.7916 | 0.00 | 0.4883 | 0.00 | -- | -- | 0.00 | -76.43 | -93.21 | -84.97 | -104.99 | -- | -- | -- | -12,332.25 | -- | -- | 0.00 | -- | -100.00 | -- | 27.85 | -- | -15.20 | -- |
| Inmode Ltd | 416.63m | 149.20m | 1.32bn | 581.00 | 10.02 | 1.91 | 8.84 | 3.18 | 1.73 | 1.73 | 4.84 | 9.09 | 0.5228 | 1.62 | 11.78 | 717,084.30 | 18.72 | 31.32 | 20.79 | 35.64 | 82.27 | 84.46 | 35.81 | 39.65 | 8.09 | -- | 0.00 | 0.00 | 8.32 | 37.49 | 22.54 | 54.65 | 13.10 | -- |
| Integra Lifesciences Holdings Corp | 1.57bn | 23.65m | 1.33bn | 3.95k | 57.95 | 0.8678 | 8.73 | 0.8499 | 0.2961 | 0.2961 | 20.02 | 19.77 | 0.399 | 1.55 | 5.81 | 396,986.10 | 0.6023 | 3.33 | 0.6618 | 3.68 | 61.54 | 63.67 | 1.51 | 7.99 | 2.10 | 5.88 | 0.5433 | 0.00 | -1.03 | 0.9219 | -62.48 | 2.19 | -2.97 | -- |
| AtriCure Inc | 429.95m | -40.12m | 1.37bn | 1.20k | -- | 2.96 | -- | 3.18 | -0.8606 | -0.8606 | 9.22 | 9.49 | 0.7217 | 1.68 | 8.27 | 358,294.20 | -6.73 | -3.72 | -7.58 | -4.10 | 74.84 | 74.36 | -9.33 | -7.64 | 2.93 | -11.79 | 0.12 | -- | 20.84 | 14.64 | 34.49 | -- | 46.56 | -- |
| Adapthealth Corp | 3.26bn | -692.75m | 1.55bn | 10.70k | -- | 1.03 | -- | 0.4738 | -5.17 | -5.17 | 24.29 | 11.14 | 0.6714 | 22.22 | 8.12 | 304,741.80 | -14.15 | -4.34 | -15.89 | -4.89 | 18.63 | 18.28 | -21.07 | -6.47 | 0.9438 | 2.17 | 0.5866 | -- | 7.73 | -- | -1,169.99 | -- | -- | -- |
| STAAR Surgical Co | 332.94m | 16.61m | 1.58bn | 1.06k | 96.06 | 3.87 | 71.67 | 4.75 | 0.335 | 0.335 | 6.75 | 8.32 | 0.6984 | 2.13 | 3.54 | 315,286.00 | 3.49 | 6.77 | 3.99 | 7.90 | 79.24 | 76.89 | 4.99 | 9.16 | 5.21 | -- | 0.0003 | 0.00 | 13.37 | 21.07 | -46.18 | 33.85 | 51.95 | -- |
| Warby Parker Inc | 719.93m | -45.90m | 1.78bn | 2.14k | -- | 5.41 | -- | 2.48 | -0.387 | -0.387 | 6.05 | 2.75 | 1.22 | 5.68 | 603.46 | 336,415.40 | -7.78 | -- | -9.68 | -- | 55.37 | 57.49 | -6.38 | -14.53 | 2.11 | -- | 0.00 | -- | 11.98 | 19.67 | 42.75 | -- | -- | -- |
| Patterson Companies, Inc. | 6.53bn | 168.41m | 1.92bn | 7.60k | 11.88 | 2.01 | 7.43 | 0.2933 | 1.83 | 1.83 | 71.22 | 10.80 | 2.27 | 5.86 | 15.35 | 859,640.70 | 5.84 | 1.13 | 10.15 | 1.81 | 21.03 | 20.98 | 2.57 | 0.5157 | 0.6723 | 7.91 | 0.4474 | 304.75 | 1.50 | 3.34 | -10.42 | 18.10 | 2.17 | 0.00 |
| Novocure Ltd | 549.96m | -168.70m | 1.95bn | 1.45k | -- | 5.38 | -- | 3.55 | -1.58 | -1.58 | 5.13 | 3.35 | 0.4639 | 3.62 | 8.11 | 378,502.40 | -14.23 | -7.74 | -16.44 | -8.95 | 75.83 | 77.22 | -30.67 | -14.69 | 6.22 | -- | 0.6437 | -- | -5.30 | 15.47 | -123.75 | -- | 32.19 | -- |
| LeMaitre Vascular Inc | 205.62m | 37.68m | 2.00bn | 614.00 | 53.22 | 6.25 | 42.21 | 9.71 | 1.67 | 1.67 | 9.11 | 14.22 | 0.5964 | 1.13 | 7.19 | 334,887.60 | 10.93 | 9.02 | 11.81 | 9.93 | 67.70 | 65.83 | 18.32 | 15.45 | 5.86 | -- | 0.00 | 40.41 | 19.69 | 12.88 | 45.89 | 5.96 | 18.93 | 15.51 |
| Premier Inc | 1.35bn | 119.54m | 2.06bn | 2.90k | 19.79 | 1.10 | 8.73 | 1.53 | 1.04 | 1.04 | 11.78 | 18.68 | 0.3976 | 5.85 | 3.07 | 464,262.40 | 3.15 | 7.08 | 4.10 | 8.95 | 65.96 | 61.29 | 7.93 | 16.05 | 0.8951 | -- | 0.2775 | 27.32 | 0.7684 | 2.03 | -31.70 | -11.93 | -2.76 | -- |
| Omnicell Inc | 1.08bn | -20.76m | 2.07bn | 3.65k | -- | 1.72 | 31.96 | 1.91 | -0.4558 | -0.4558 | 23.63 | 26.15 | 0.4818 | 5.64 | 4.20 | 296,013.40 | -0.9258 | 1.73 | -1.12 | 2.25 | 41.63 | 46.69 | -1.92 | 2.92 | 2.22 | -- | 0.322 | 0.00 | -11.48 | 7.82 | -460.68 | -- | 0.235 | -- |
Data as of Sep 18 2024. Currency figures normalised to STAAR Surgical Co's reporting currency: US Dollar USD
63.07%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Broadwood Capital, Inc.as of 30 Jun 2024 | 10.77m | 21.89% |
| BlackRock Fund Advisorsas of 30 Jun 2024 | 6.91m | 14.04% |
| The Vanguard Group, Inc.as of 30 Jun 2024 | 5.36m | 10.89% |
| SSgA Funds Management, Inc.as of 30 Jun 2024 | 1.93m | 3.92% |
| Baillie Gifford & Co.as of 30 Aug 2024 | 1.56m | 3.18% |
| Palo Alto Investors LPas of 30 Jun 2024 | 1.38m | 2.81% |
| Geode Capital Management LLCas of 30 Jun 2024 | 1.14m | 2.32% |
| Geneva Capital Management LLCas of 30 Jun 2024 | 693.17k | 1.41% |
| Defender Capital LLCas of 30 Jun 2024 | 649.19k | 1.32% |
| Northern Trust Investments, Inc.(Investment Management)as of 30 Jun 2024 | 630.26k | 1.28% |
More ▼
Data from 30 Jun 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
